comorbid psychiatric disorder
Recently Published Documents


TOTAL DOCUMENTS

13
(FIVE YEARS 1)

H-INDEX

5
(FIVE YEARS 0)

2015 ◽  
Vol 51 ◽  
pp. 64-69 ◽  
Author(s):  
Michael Kidorf ◽  
Van L. King ◽  
Jessica Peirce ◽  
Neeraj Gandotra ◽  
Sharon Ghazarian ◽  
...  

2014 ◽  
Vol 204 (6) ◽  
pp. 430-435 ◽  
Author(s):  
Ping Qin ◽  
Keith Hawton ◽  
Preben Bo Mortensen ◽  
Roger Webb

BackgroundPeople with physical illness often have psychiatric disorder and this comorbidity may have a specific influence on their risk of suicide.AimsTo examine how physical illness and psychiatric comorbidity interact to influence risk of suicide, with particular focus on relative timing of onset of the two types of illness.MethodBased on the national population of Denmark, individual-level data were retrieved from five national registers on 27 262 suicide cases and 468 007 gender- and birth-date matched living controls. Data were analysed using conditional logistic regression.ResultsBoth suicides and controls with physical illness more often had comorbid psychiatric disorder than their physically healthy counterparts. Although both physical and psychiatric illnesses constituted significant risk factors for suicide, their relative timing of onset in individuals with comorbidity significantly differentiated the associated risk of suicide. While suicide risk was highly elevated when onsets of both physical and psychiatric illness occurred close in time to each other, regardless which came first, psychiatric comorbidity developed some time after onset of physical illness exacerbated the risk of suicide substantially.ConclusionsSuicide risk in physically ill people varies substantially by presence of psychiatric comorbidity, particularly the relative timing of onset of the two types of illness. Closer collaboration between general and mental health services should be an essential component of suicide prevention strategies.


2014 ◽  
Vol 5 (1) ◽  
pp. 117
Author(s):  
Amit Bhattacharya ◽  
Somsubhra Chatterjee ◽  
Subir Bhattacharya ◽  
Rajarshi Chakraborty ◽  
Amitava Dan ◽  
...  

2010 ◽  
Vol 197 (2) ◽  
pp. 91-95 ◽  
Author(s):  
Norman A Poole ◽  
Axel Wuerz ◽  
Niruj Agrawal

BackgroundThe value of drug interviews in the treatment of conversion disorder is at present unknown.AimsTo review all the available papers published in English that report on the use of drug interviews for treating conversion/dissociative disorder.MethodDatabases (including EMBASE, MEDLINE and PsycINFO) were searched from 1920 to 2009. Selected publications had to report on the use of drug interviews in people diagnosed with a conversion/dissociative disorder. Qualitative and quantitative data were extracted. Predictors of a positive response were ascertained using meta-analytic techniques.ResultsFifty-five papers meeting inclusion criteria were identified. No studies compared the intervention with a suitable control group. However, two studies reported high response rates when drug interview was used in individuals with treatment-resistant conversion disorder. In the meta-analysis, the use of suggestion and occurrence of emotional catharsis during the interview were positively associated with recovery. Combining two medications and comorbid psychiatric disorder were negatively associated with recovery.ConclusionsThe evidence for effectiveness of drug interviews is of poor quality but it may be of benefit in the treatment of acute and treatment-resistant conversion disorder. A proactive approach during the interview, making suggestions the individual will respond, could influence outcome. Comorbid psychiatric disorder should be treated conventionally. Experimental studies to determine efficacy are required.


Sign in / Sign up

Export Citation Format

Share Document